Psoriasis and autoimmune diseases

All Items

• Psoriasis and Genetics

  Nick Dand, Satveer K. Mahil, Francesca Capon, Catherine H. Smith, Michael A. Simpson, Jonathan N. Barker

  54-64

• Psoriasis in Norway: A Prescription-based Registry Study of Incidence and Prevalence

  Silje Michelsen Solberg

  adv4591

• Psoriasis on the Leg: Site-specific Histopathological and Immuno­histochemical Features and Diagnostic Difficulties

  Mihaela Fülle, Dieter Metze, Almut Böer-Auer, Nani Osada, Stephan A. Braun

  adv00453

• Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations

  Åsa Krantz, Juan Jesus Carrero, Yuanhang Yang, Lovisa Schalin, Josefin Lysell, Faizan Mazhar

  adv6505

• Psoriatic Insomnia: A Subjective and Objective Sleep Evaluation

  Katerina Vlami, Kleoniki Pantelidi, Maria Dalamaga, Fani Karagianni, Konstantinos Theodoropoulos, Spyridon Papiris, Evangelia Papadavid

  adv00864

• Pustular Psoriasis: The Dawn of a New Era

  Hervez Bachelez

  87-92

• Quality of Life and Psychopathology in Lichen Planus: A Neglected Disease Burden

  Zeno Fiocco, Sophie Kupf, Leilah Patzak, Till Kämmerer, Teodora Pumnea, Lars E. French, Markus Reinholz

  adv00619

• Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

  Riccardo G. Borroni, Piergiorgio Malagoli, Luigi Gargiulo , Mario Valenti, Giulia Pavia, Paola Facheris, Emanuela Morenghi, Isotta Giunipero di Corteranzo, Alessandra Narcisi, Michela Ortoncelli, Paolo Dapavo, Antonio Costanzo

  adv00605

• Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis

  Marloes E. van Muijen, Sarah E. Thomas, Douwe Vellinga, Silke Bouwman, Martijn B.A. van Doorn, Klaziena Politiek, Marisol E. Otero, Juul M.P.A. van den Reek, Elke M.G.J. de Jong

  adv00755

• Real-world Methotrexate Use in a Prospective Cohort of Paediatric Patients with Plaque Psoriasis: Effectiveness, Adverse Events and Folic Acid Regimen

  Finola M. Bruins, Maartje R. van Acht, Inge M.G.J. Bronckers, Hans M.M. Groenewoud, Elke M.G.J. de Jong, Marieke M.B. Seyger

  adv00745

• Relationship Between Pemphigus Vulgaris Severity and PCR-positive Herpes Simplex Virus

  Sharon Baum, Itai Atar, Dan Coster, Sara Dovrat, Michal Solomon, Eli Sprecher, Tal Zeeli, Aviv Barzilai

  adv00703

• Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study

  Nikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, Lars Erik Bryld, Christoffer V. Nissen, Tomas Norman Dam, Kawa Khaled Ajgeiy, Lars Iversen, Lone Skov

  adv00357

• Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study

  Nikolai Loft, Alexander Egeberg, Daniel Isufi, Mads K. Rasmussen, Lars E. Bryld, Tomas N. Dam, Kawa K. Ajgeiy, Trine Bertelsen, Lone Skov

  adv12616

• Risk of Head and Neck Cancer in Patients with Psoriasis: A Nationwide Population-based Study

  Gene Huh, Dongjun Kim, Kyu-na Lee, Kyungdo Han, Jung-Hae Cho

  adv18487

• Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy

  Luca Mastorino, Paolo Dapavo, Mattia Trunfio, Gianluca Avallone, Marco Rubatto, Andrea Calcagno, Simone Ribero, Pietro Quaglino

  adv00821

• Risk of Serious Infections in Patients with Bullous Pemphigoid: A Population-based Cohort Study

  Tsung-Hsien Chang, Chun-Ying Wu, Yun-Ting Chang, Ying-Syuan Lyu, Chen-Yi Wu

  adv5329

• Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report

  Birao Fan, Mingyue Wang

  adv00732

• Safety and Efficacy of Topical Calcineurin Inhibitors in the Treatment of Facial and Genital Psoriasis: A Systematic Review

  Diva Amiri, Christopher Willy Schwarz, Lise Gether, Lone Skov

  adv00890

• Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study

  Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof , Elke M.G.J. de Jong , Satish F.K. Lubeek

  adv00805

• Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials

  Kristian Reich, Diamant Thaçi, Georg Stingl, Jens Strodl Andersen, Line Conradsen Hiort, Michala Oron Lexner, David Winkler, Carle Paul

  adv00683

• Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study

  Antonio Costanzo, Filomena Russo, Marco Galluzzo, Luca Stingeni, Roberta Scuderi, Leonardo Zichichi, Manuela Papini, Luisa Di Costanzo, Andrea Conti, Martina Burlando, Andrea Chiricozzi, Francesca Maria Gaiani, Cristina Mugheddu, Maria Letizia Musumeci, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Marina Venturini, Gianluca Pagnanelli, Paolo Amerio, Concetta Potenza, Ketty Peris, Franca Cantoresi, Sara Trevisini, Francesco Loconsole, Annamaria Offidani, Santo Raffaele Mercuri, Viviana Lora, Francesca Prignano, Marta Bartezaghi, Giovanni Oliva, Elisabetta Aloisi, Roberto Orsenigo

  adv00576

• Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study

  Marina Talamonti, Giovanna Malara, Ylenia Natalini, Federico Bardazzi, Andrea Conti, Andrea Chiricozzi, Cristina Mugheddu, Paolo Gisondi, Stefano Piaserico, Gianluca Pagnanelli, Paolo Amerio, Concetta Potenza, Franca Cantoresi, Maria Concetta Fargnoli, Anna Balato, Francesco Loconsole, Annamaria Offidani, Claudio Bonifati, Francesca Prignano, Marta Bartezaghi, Alice Rausa, Elisabetta Aloisi, Roberto Orsenigo, Antonio Costanzo

  adv00422

• Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study

  Lina Renkhold, Manuel P. Pereira, Karin Loser, Dieter Metze, Daniel Baeumer, Nima Melzer, Maximilian Reinhardt, Athanasios Tsianakas, Thomas Luger, Christian Mess, Ruth Becker, Clara Hambüchen, Konstantin Agelopoulos, Sonja Ständer

  adv40737

• Serum 5-Hydroxytryptamine is Related to Psoriasis Severity in Patients with Comorbid Anxiety or Depression

  Minxue Shen, Duling Cao, Yi Xiao, Yehong Kuang, Danrong Jing, Yajia Li, Panpan Liu, Xiang Chen, Wu Zhu

  adv00514

• Sex-differences in Gluten-free Dietary Adherence and Clinical Symptoms in Patients with Long-term Treated Dermatitis Herpetiformis

  Camilla Pasternack, Kaisa Hervonen, Eriika Mansikka, Timo Reunala, Katri Kaukinen, Teea Salmi

  adv00713

• Significant Correlation Between Cutaneous Abundance of Streptococcus and Psoriasis Severity in Patients with FBXL19 Gene Variants

  Malin Assarsson, Jan Söderman, Oliver Seifert

  adv34892

• Skin Eosinophil Counts in Bullous Pemphigoid as a Prognostic Factor for Disease Severity and Treatment Response

  Sharon Baum, Maya Engler Markowitz, Anna Lyakhovitsky, Rotem Gershon, Hannah Aviv, Zvi Segal, Aviv Barzilai

  adv00850

• Sleep Disorders and Psoriasis: An Update

  Bruno Halioua, Clara Chelli, Laurent Misery, Jonathan Taieb, Charles Taieb

  adv00699

• Sociodemographic and Environmental Determinants of Regional Prevalence of Psoriasis in Germany: A Spatiotemporal Study of Ambulatory Claims Data

  Valerie Andrees, Sandra Wolf, Marie Sander, Matthias Augustin, Jobst Augustin

  adv12430

• Statin Therapy and Vascular Inflammation Detected by Positron Emission Tomography/Computed Tomography in Patients with Psoriasis

  Hannah Kaiser, Amanda Kvist-Hansen, Martin Krakauer, Peter Michael Gørtz, Kristoffer Mads Aaris Henningsen, Xing Wang, Christine Becker, Lone Skov, Peter Riis Hansen

  adv00406

• Steroid Refractory Figurate Eruption with Eosinophilia in a Young Adult Man: A Quiz

  Gabriela Żuk, Dominik Samotij, Justyna M. Szczęch, Adam Reich

  adv00450

• Successful Therapy of Severe and Refractory Cutaneous Sarcoidosis with Baricitinib

  Giuseppe Russo, Emmanuel Laffitte

  adv39970

• Successful Treatment of Mucous Membrane Pemphigoid with Dupilumab: A Case Report

  Zhiyi Wang, Xiaojing Liu, Jing Ni, Yushuo Qi, Zhiqi Song, Yongjun Piao

  adv40162

• Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris

  Katharina Boch; Ewan A. Langan; Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Katja Bieber, Christoph M. Hammers

  adv00679

• Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3

  Alexander Egeberg, Lars Erik Kristensen, Ronald Vender, Shirin Zaheri, Celine El Baou, Gaia Gallo, Elisabeth Riedl, Christopher Schuster

  adv00787

• The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study Intervention against Stigmatisation of Psoriasis

  Simona Maspero, Christopher Ebert, Selina Moser, Alexander Zink, Pablo Sichert, Maximilian Schielein, Johanna Weis, Stefanie Ziehfreund

  adv3513

• The Woronoff Ring in Psoriasis and the Mechanisms of Postinflammatory Hypopigmentation

  Jörg C. Prinz

  65-68

• Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents

  Audrey Melin, Jean-François Sei, Florence Corgibet, Cristèle Nicolas, Rémi Maghia, Bruno Halioua, Alain Beauchet, Emmanuel Mahé

  adv00514

• Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis

  Kim Papp, Carle Paul, C. Elise Kleyn, Yu-Huei Huang, Tsen-Fang Tsai, Christopher Schuster, Celine El Baou, Agoston Toth, Elisabeth Riedl, Ulrich Mrowietz

  adv00672

• Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications

  Anna M. Halupczok, Ann-Sophie Bohne, Sascha Gerdes, Stephan Weidinger, Michael Weichenthal

  adv35215

• Traditional and Non-traditional Cardiovascular Risk Factors and Cardiovascular Disease in Women with Psoriasis

  Charlotte Näslund-Koch, Signe Vedel-Krogh, Stig Egil Bojesen, Lone Skov

  adv00789

• Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

  Päivi Leisti, Anna Pankakoski, Jari Jokelainen, Laura Huilaja, Jaana Panelius, Kaisa Tasanen, Outi Varpuluoma

  adv40645

• Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

  Néboa Zozaya, Renata Villoro, Fernando Abdalla, Santiago Alfonso Zamora, Jesús Balea Filgueiras, José Manuel Carrascosa Carrillo, Olga Delgado Sánchez, Francisco Dolz Sinisterra, Antonio García-Ruiz, Pedro Herranz Pinto, Antonio Manfredi, José Martínez Olmos, Paloma Morales de los Ríos Luna, Lluis Puig Sanz, Sandra Ros, Álvaro Hidalgo

  adv00678

• Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis

  Birgit Sadoghi, Birger Kränke, Lorenzo Cerroni, Wolfgang Weger

  adv00593

• Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy

  Camille Scard, Corina Bara-Passot, Kévin Chassain, Hervé Maillard

  adv00415

• Updated Role of High-frequency Ultrasound in Assessing Dermatological Manifestations in Autoimmune Skin Diseases

  Ke Chai, Ruixuan Zhu, Fujian Luo, Yaqian Shi, Minghui Liu, Yangfan Xiao, Rong Xiao

  adv00765

• Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

  Chul Hwan Bang, Hyun Ju Oh, Yeong Ho Kim, Jin-Hyung Jung, Ji Hyun Lee, Young Min Park, Ju Hee Han

  adv34206